Clinical Study
Venous Outflow Reconstruction in Adult Living Donor Liver Transplant: Outcome of a Policy for Right Lobe Grafts without the Middle Hepatic Vein
Table 8
Outcome in terms of laboratory findings (total bilirubin), overall hospital stay, three-month survival, and one-year survival.
| | Parameters | Group A (reconstruction patients with more than one HV anast.) () | Group B (patients with single HV anast.) () |
| | Total bilirubin | | | | 3-day level (mg/dL) | Median 3.25 + range (1.6–6) | Median 2.25 + range (0.3–10) | | 1-month level (mg/dL) | Median 0.8 + range (0.2–5.5) | Median 1 + range (0.5–27) | | Hospital stay (days) | Median 27 + range (13–51) | Median 25 range (5–84) | | Three-month survival | 15 (93.75%) | 19 (79.16%) | | One-year survival | 14 (87.5%) | 17 (70.83%) |
|
|
